Northwest Biotherapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NWBO | VRXA | CMPX | ANIX | NBP | CADL | |
|---|---|---|---|---|---|---|
| Market cap | 272.90M | 147.06M | 154.88M | 92.47M | 152.54M | 624.39M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -2.3 | — | -1.6 | -8.6 | -1.2 | -13.1 |
| Price/book | -5.9 | -0.8 | 0.9 | 6.4 | 0.8 | 4.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −27.27% | −89.43% | −78.77% | −37.76% | −75.86% | +47.83% |
| Today | +6.67% | −6.31% | −4.09% | −0.37% | +4.35% | −0.37% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All NWBO news ›Bethesda’s Northwest Biotherapeutics Partners With UK’s NHS Blood and Transplant to Support DCVax®-L Production
“NHSBT’s impressive expertise and facilities for advanced therapies are at the forefront of the field. We are very excited about collaborating with them on our DCVax®-L personalised immune therapies for cancer. We believe NHSBT’s…
NHS Blood and Transplant partners with Northwest Biotherapeutics
by John Pinching | 12th Oct 2026 | News Northwest Biotherapeutics and NHS Blood and Transplant have agreed a collaboration to support production of DCVax-L, a personalised immunotherapy for solid tumour cancers. The partnership will begin…
Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax®-L Production
Oct 08, 2026, 16:53 ET NHS Blood and Transplant's specialist therapeutic apheresis and cell processing capabilities are supporting the production of DCVax®-L, with plans to expand the model to additional locations across England. NHS Blood…
News from Northwest Biotherapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
news News from Northwest Biotherapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. 17:01 ET…
Northwest Biotherapeutics partners with UK NHS to produce experimental cancer vaccine DCVax-L
Northwest Biotherapeutics has partnered with the UK National Health Service Blood and Transplant (NHSBT) to support production of its experimental cancer vaccine DCVax-L, targeting glioblastoma and other solid tumors. NHSBT's therapeutic…
Northwest Biotherapeutics Announces Keynote Presentation on Harnessing Immunity: A Personalized, Multi-Target Approach to Cancer At the UK National Health Service Annual Oncology Conference
PA Media Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the…
Northwest Biotherapeutics CTO to keynote UK NHS CancerCare conference on personalized cancer vaccines.
Northwest Biotherapeutics announced that its CTO, Dr. Marnix Bosch, will deliver a keynote at the UK NHS CancerCare Oncology Conference discussing personalized dendritic cell-based cancer vaccines like DCVax®. The presentation will cover…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
pluang.com1
-
prnewswire.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.